Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4111 USD | -0.48% | -15.52% | +50.59% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 28.1M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -27M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.47
x | P/E ratio 2025 * |
-1.1
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.62% |
Latest transcript on Brainstorm Cell Therapeutics Inc.
1 day | -0.48% | ||
1 week | -15.52% | ||
Current month | -15.52% | ||
1 month | -11.97% | ||
3 months | +24.58% | ||
6 months | +105.24% | ||
Current year | +50.59% |
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 07-06-30 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 12-12-22 |
Chief Tech/Sci/R&D Officer | - | 22-05-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 00-09-21 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
Jacob Frenkel
CHM | Chairman | 81 | 20-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.4111 | -0.48% | 377,743 |
24-06-06 | 0.4131 | -5.36% | 614,560 |
24-06-05 | 0.4365 | -0.64% | 343,904 |
24-06-04 | 0.4393 | -12.14% | 681,239 |
24-06-03 | 0.5 | +2.75% | 346,593 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.59% | 28.1M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- BCLI Stock